Lomon Bio launches the world’s first registered biological miticide
AgriBusiness Global
2026.04.13
As agricultural mite resistance intensifies globally, Lomon Bio has unveiled a landmark solution: BIMIE, the world’s first registered biological miticide. Backed by the Lomon Group — a global powerhouse in phosphorus and titanium chemicals —Sichuan Lomon Bio Technology Co., Ltd. is a renowned leader in Plant Growth Regulators (PGR), recognized as a premier producer of S-Abscisic Acid (S-ABA) and Gibberellic Acid (GA3).
The launch of BIMIE® marks a strategic evolution into biopesticides, targeting Citrus Red Mites and aphids across high-value crops such as citrus, pomegranates, peppers, and watermelons. BIMIE has already delivered outstanding results in major agricultural hubs like Sichuan and Guangxi. In extensive citrus trials, it achieved a 95% control efficacy within 24 hours and maintained protection for up to 20 days. Even in regions with severe chemical resistance, its potent ovicidal activity effectively disrupts mite populations at the source, surpassing conventional treatments.
As agricultural mite resistance intensifies globally, Lomon Bio has unveiled a landmark solution: BIMIE, the world’s first registered biological miticide. Backed by the Lomon Group — a global powerhouse in phosphorus and titanium chemicals —Sichuan Lomon Bio Technology Co., Ltd. is a renowned leader in Plant Growth Regulators (PGR), recognized as a premier producer of S-Abscisic Acid (S-ABA) and Gibberellic Acid (GA3).
The launch of BIMIE® marks a strategic evolution into biopesticides, targeting Citrus Red Mites and aphids across high-value crops such as citrus, pomegranates, peppers, and watermelons. BIMIE has already delivered outstanding results in major agricultural hubs like Sichuan and Guangxi. In extensive citrus trials, it achieved a 95% control efficacy within 24 hours and maintained protection for up to 20 days. Even in regions with severe chemical resistance, its potent ovicidal activity effectively disrupts mite populations at the source, surpassing conventional treatments.
Read more here.